Luis E Fayad

Associate Professor

  • 9479 Citations
  • 54 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 38 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Feb 1 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journalLetter

Hodgkin Disease
Rituximab
Marginal Zone B-Cell Lymphoma
Breast
Salvage Therapy
Radiotherapy
Therapeutics

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Chihara, D., Oki, Y., Fanale, M. A., Westin, J. R., Nastoupil, L., Neelapu, S. S., Fayad, L. E., Fowler, N. & Cheah, C. Y., Jan 1 2019, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Survival
Lymphoma
Peripheral T-Cell Lymphoma
Mantle-Cell Lymphoma
6 Citations (Scopus)

Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: Final results from the PILLAR-2 randomized phase III trial

Witzig, T. E., Tobinai, K., Rigacci, L., Ikeda, T., Vanazzi, A., Hino, M., Shi, Y., Mayer, J., Costa, L. J., Bermudez Silva, C. D., Zhu, J., Belada, D., Bouabdallah, K., Kattan, J. G., Kuruvilla, J., Kim, W. S., Larouche, J. F., Ogura, M., Ozcan, M., Fayad, L. E. & 5 othersWu, C., Fan, J., Louveau, A. L., Voi, M. & Cavalli, F., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 707-714 8 p., mdx821.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Placebos
Lymphoma
Everolimus